Delivery Order SPE2DB20D7061-SPE2DB24FSPD4
Award Date
7/24/24
Potential Completion Date
7/25/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,050,308 units of Infliximab 100 mg vials, with a ceiling value of $6,282.00. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,699.90 firm fixed-price delivery order is for the supply of 4,568,061,467 vials of the medication Infliximab 100 mg. The contract has an ultimate completion date of April 29, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA...
The Defense Logistics Agency (DLA) awarded a $10,017.36 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,835,720 units of Infliximab 100 mg vials. The contract has a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery...
This federal contract award, valued at $3,678.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,163,074 units of Infliximab 100 mg vials, a specialty medication used for the treatment of various medical conditions. The award is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a delivery order under a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $999,999,999, is an Indefinite Delivery Contract (IDC) that provides a range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This specific delivery order, valued at $4,789.29, is for the supply of 100 mg vials of the drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Remicade (infliximab) 100 mg vials. The contract has a ceiling value of $5,582.95 and a period of performance through July 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $14,352.96, is for the delivery of 4565262001 - INFLIXIMAB 100 MG VIALS. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFLIXIMAB 100 MG VIALS, a specialty medication, with a ceiling value of $20,680.42. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) worth $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $23,954.18 and covers the delivery of Remicade 100 mg vials. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,904,290 units of the pharmaceutical product Inflectra 100 mg vials. The contract has a ceiling value of $9,504.72 and a completion date of September 24, 2024. This contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery contracts with various agencies,...